Améliorer le consensus autour de l’évaluation de la synovite dans la polyarthrite rhumatoïde
Peter Cheung(Délégation Paris 5), Laure Gossec(Inserm), Nathalie Balandraud, Stéphane Pavy, Gaël Mouterde(Hôpital Lapeyronie), Ghislaine Gill(Centre Hospitalier Régional et Universitaire de Nancy), Gérard Chalès(Inserm), Martin Soubrier(Centre Hospitalier Universitaire de Clermont-Ferrand), Isabelle Chary-Valckenaere(Centre National de la Recherche Scientifique), F. Pouyol(Centre Hospitalier Universitaire de Lille), Emmanuelle Dernis(Centre Hospitalier du Mans), Sandrine Guis(Centre National de la Recherche Scientifique), Emmanuel Chatelus(Laboratoire National de Référence), Pascal Richette(Inserm), Maxime Dougados(Délégation Paris 5), Mélanie Gilson(Centre Hospitalier Universitaire de Grenoble), Thierry Marhadour(Centre Hospitalier Régional Universitaire de Brest), André Vincent(Centre Hospitalier du Mans), Adeline Ruyssen‐Witrand(Centre Hospitalier Universitaire de Toulouse)
Cited by 0
Related Papers
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
|Annals of the Rheumatic Diseases|2020|2.8k
2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease‐modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis
|Arthritis Care & Research|2012|1.8k
Abatacept for Rheumatoid Arthritis Refractory to Tumor Necrosis Factor α Inhibition
|New England Journal of Medicine|2005|1.2k
EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)
|Annals of the Rheumatic Diseases|2006|798
A multicenter, randomized, double‐blind, placebo‐controlled trial of adjuvant methotrexate treatment for giant cell arteritis
|Arthritis & Rheumatism|2002|574